未登录

Z

Zeyu Zhong

University of Melbourne

H指数:17

被引数:741

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Disentangling Structural Breaks in Factor Models for Macroeconomic Data

解耦宏观经济数据因子模型中的结构断裂

JOURNAL OF BUSINESS & ECONOMIC STATISTICS

IF2.5

2025-12-010

PRE

Multi-Segment Extendable Soft Manipulator Driven by a Pneumatic–Tendon Coupling Mechanism

多段可伸展软体机械手，由气动-肌腱耦合机制驱动

Biomimetics 2025, Vol. 10, Page 643

IF3.9

2025-09-270

OAAI

Discovery of HMPL-306 (Ranosidenib), a New Potent and Selective Dual Inhibitor of Mutant IDH1 and 2 in Clinical Development for Cancer Treatment

ACS MEDICINAL CHEMISTRY LETTERS

IF4

2025-02-130

PRE

Preclinical characterization of HMPL-295, a potent and selective ERK 1/2 inhibitor

CANCER RESEARCH

IF16.6

2024-03-220

PRE

HMPL-506, a novel, highly potent and differentiated menin-MLL inhibitor for the treatment of MLL- rearrangedand NPM1mutant acute leukemia in preclinical models

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Preclinical characterization of HMPL-415, a second-generation SHP2 inhibitor

MOLECULAR CANCER THERAPEUTICS

IF5.5

2023-12-010

PRE

A Novel Anti-ESD-Enhanced Single Photon Avalanche Diode for Industry-Level Fluorescence Detection

IEEE SENSORS JOURNAL

IF4.5

2023-12-010

PRE

DNA 5-methylcytosine detection and methylation phasing using PacBio circular consensus sequencing

NATURE COMMUNICATIONS

IF15.7

2023-07-0825

OAAI

Preclinical characteristic of HMPL-306, a CNS-penetrable dual inhibitor of mutant IDH1 and IDH2

CANCER RESEARCH

IF16.6

2023-04-041

PRE

HMPL-453, a highly selective inhibitor of fibroblast growth factor receptors 1, 2, and 3, displays potent activity in FGFR-altered tumor models

CANCER RESEARCH

IF16.6

2023-04-041

PRE

Energy collection generator based on electrostatic conversion mechanism

基于静电转换机制的能量收集发生器

JOURNAL OF SCIENCE-ADVANCED MATERIALS AND DEVICES

IF6.8

2022-12-015

OAAI

Fog Radio Access Networks With Hierarchical Content Delivery

IF3.6

2019-01-014

OAAI

Atorvastatin impaired glucose metabolism in C2C12 cells partly via inhibiting cholesterol-dependent glucose transporter 4 translocation

阿托伐他汀部分通过抑制胆固醇依赖性葡萄糖转运蛋白4易位影响C2C12细胞糖代谢

BIOCHEMICAL PHARMACOLOGY

IF5.6

2018-04-0121

PREAI

The enhanced atorvastatin hepatotoxicity in diabetic rats was partly attributed to the upregulated hepatic Cyp3a and SLCO1B1

SCIENTIFIC REPORTS

IF3.9

2016-09-1428

OAAI

In vitro metabolism of L-corydalmine, a potent analgesic drug, in human, cynomolgus monkey, beagle dog, rat and mouse liver microsomes

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2016-09-0113

OAAI

Ciprofloxacin blocked enterohepatic circulation of diclofenac and alleviated NSAID-induced enteropathy in rats partly by inhibiting intestinal β-glucuronidase activity

ACTA PHARMACOLOGICA SINICA

IF8.4

2016-05-1637

OAAI

Unconjugated bilirubin elevation impairs the function and expression of breast cancer resistance protein (BCRP) at the blood-brain barrier in bile duct-ligated rats

ACTA PHARMACOLOGICA SINICA

IF8.4

2016-05-1623

OAAI

Chronic administration of caderofloxacin, a new fluoroquinolone, increases hepatic CYP2E1 expression and activity in rats

ACTA PHARMACOLOGICA SINICA

IF8.4

2016-02-019

OAAI

Involvement of pregnane X receptor in the impaired glucose utilization induced by atorvastatin in hepatocytes

BIOCHEMICAL PHARMACOLOGY

IF5.6

2016-01-0137

PREAI

Laminaria japonica increases plasma exposure of glycyrrhetinic acid following oral administration of Liquorice extract in rats

CHINESE JOURNAL OF NATURAL MEDICINES

IF4.9

2015-07-0117

PREAI